Kent David, Sheridan Carl
Eye Service, Aut Even Hospital, Kilkenny, Ireland.
Mol Vis. 2003 Dec 22;9:747-55.
The process of submacular angiogenesis seen in association with a variety of chorioretinal disorders is termed choroidal neovascularization (CNV). It invariably results in significant and permanent vision loss arising from the development of scar tissue formation. At the cellular level, CNV appears to be a component of several key processes that can be broadly referred to as wound healing or tissue repair. Wound healing involves a coordinated cascade of cellular events driven, in the main, by the production of cytokines and which are interpreted by target cells in the context of a continually evolving extracellular matrix (ECM). A similar process occurs in what is clinically termed CNV. Angiogenesis is just one component of this wound healing process. Other key components include inflammation, matrix deposition and remodelling. Thus, in the context of a tissue repair response, viable treatment options for CNV could include therapies other than those that are currently directed at the angiogenic component of this process.
在多种脉络膜视网膜疾病中出现的黄斑下血管生成过程被称为脉络膜新生血管形成(CNV)。它总是会因瘢痕组织形成的发展而导致严重且永久性的视力丧失。在细胞水平上,CNV似乎是几个关键过程的一个组成部分,这些过程大致可被称为伤口愈合或组织修复。伤口愈合涉及一系列由细胞因子产生主要驱动的协调细胞事件级联反应,并且在不断演变的细胞外基质(ECM)环境中由靶细胞进行解读。在临床上称为CNV的情况中也会发生类似过程。血管生成只是这个伤口愈合过程的一个组成部分。其他关键组成部分包括炎症、基质沉积和重塑。因此,在组织修复反应的背景下,针对CNV的可行治疗选择可能包括目前针对该过程血管生成成分之外的其他疗法。